ConductScience.org, home

Paper33804385

PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary Center.

Semmler G and 11 others. J Pers Med, 2021. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary Center. Papers, record 33804385. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33804385

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary Center.
PubMed
Journal
J Pers Med
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.55
iCite
Revised in PubMed
2021-04-13
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Semmler GGeorghttps://orcid.org/0000-0002-0411-166X
2Balcar LLorenzhttps://orcid.org/0000-0002-6708-3061
3Oberkofler HHannes
4Zandanell SStephan
5Strasser MMichael
6Niederseer DDavidhttps://orcid.org/0000-0003-3089-1222
7Feldman AAlexandra
8Stickel FFelix
9Strnad PPavelhttps://orcid.org/0000-0002-7122-6379
10Datz CChristianhttps://orcid.org/0000-0001-7838-4532
11Paulweber BBernhard
12Aigner EElmar

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121381068Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.Hepatology2011https://conductscience.org/library/papers/21381068PubMed
229562163A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.N Engl J Med2018https://conductscience.org/library/papers/29562163PubMed
327062661EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.J Hepatol2016https://conductscience.org/library/papers/27062661PubMed
426482880A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.Nat Genet2015https://conductscience.org/library/papers/26482880PubMed
527038645PNPLA3 gene in liver diseases.J Hepatol2016https://conductscience.org/library/papers/27038645PubMed
626273621Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis.Biomed Res Int2015https://conductscience.org/library/papers/26273621PubMed
725597287A genetic risk score is associated with hepatic triglyceride content and non-alcoholic steatohepatitis in Mexicans with morbid obesity.Exp Mol Pathol2015https://conductscience.org/library/papers/25597287PubMed
833385428The Pi∗MZ Allele in Alpha-1 Antitrypsin Increases Liver-Related Outcomes in a Population-Based Study.Gastroenterology2021https://conductscience.org/library/papers/33385428PubMed
929935383The role of PNPLA3 in health and disease.Biochim Biophys Acta Mol Cell Biol Lipids2019https://conductscience.org/library/papers/29935383PubMed
1032213023Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.United European Gastroenterol J2020https://conductscience.org/library/papers/32213023PubMed
1132068025Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond.Gastroenterology2020https://conductscience.org/library/papers/32068025PubMed
1231705824Patatin-Like Phospholipase Domain-Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. Population.Hepatology2020https://conductscience.org/library/papers/31705824PubMed
1319126586Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies.Am J Epidemiol2009https://conductscience.org/library/papers/19126586PubMed
1432268028Alpha1-Antitrypsin Deficiency.N Engl J Med2020https://conductscience.org/library/papers/32268028PubMed
1531121167Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.Gastroenterology2019https://conductscience.org/library/papers/31121167PubMed
1621254164Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians.Hepatology2011https://conductscience.org/library/papers/21254164PubMed
1730068662Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis.Gut2019https://conductscience.org/library/papers/30068662PubMed
1814684378Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency.Am J Physiol Gastrointest Liver Physiol2004https://conductscience.org/library/papers/14684378PubMed
1921334404Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease.J Hepatol2011https://conductscience.org/library/papers/21334404PubMed
2022899556Determination of reliability criteria for liver stiffness evaluation by transient elastography.Hepatology2013https://conductscience.org/library/papers/22899556PubMed

See all 34 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
41795966Reply to: "Gene-environment "amplification" of liver stiffness requires more clinically meaningful analytic approaches".JHEP Rep2026https://conductscience.org/library/papers/41795966PubMed
40004054Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies.Int J Mol Sci2025https://conductscience.org/library/papers/40004054PubMed
39997697From Pathophysiology to Practice: Evolving Pharmacological Therapies, Clinical Complications, and Pharmacogenetic Considerations in Portal Hypertension.Metabolites2025https://conductscience.org/library/papers/39997697PubMed
37378670A single-nucleus transcriptomic atlas of primate liver aging uncovers the pro-senescence role of SREBP2 in hepatocytes.Protein Cell2024https://conductscience.org/library/papers/37378670PubMed
36858953Identification of alternative splicing events related to fatty liver formation in duck using full-length transcripts.BMC Genomics2023https://conductscience.org/library/papers/36858953PubMed
36176936Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease.JHEP Rep2022https://conductscience.org/library/papers/36176936PubMed
35204498Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.Diagnostics (Basel)2022https://conductscience.org/library/papers/35204498PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33804385

GET https://conductscience.org/api/papers/v1/33804385/references?page=2